To further determine the molecular mechanisms underlying protumorigenic effect of SETDB1 in myeloma cells, we firstly performed differential gene expression analysis between the SETDB1high (N = 106) and SETDB1low (N = 106) groups from GSE136337 [27]. Here, SETDB1 is linked to plasma cell myeloma.